| Literature DB >> 32033177 |
Hoang-Sa Dang1, Thuy-Mai-Trinh Nguyen1, Chia-Nan Wang1, Jen-Der Day1, Thi Minh Han Dang2.
Abstract
The Asia-Pacific region is known as a favorite destination for global medical travelers due to its medical expertise, innovative technology, safety, attractive tourism destination and cost advantage in the recent decade. This study contributes to propose an approach which effectively assesses performance of medical tourism industry based on considering the economic impact factors as well as provides a conceptual framework for the industry analysis. Grey system theory is utilized as a major analyzing approach. According to that, factors impact on the sustainable development of medical tourism in Asia-Pacific region could be identified. The performance of each destination in this region was simultaneously revealed. The results presented an overall perspective of the medical tourism industry in the scope of the Asia-Pacific region, and in Taiwan particularly. Data was collected on six major destinations including Singapore, Thailand, India, South Korea, Malaysia and Taiwan. The results proved that tourism sources and healthcare medical infrastructures play a crucial role in promoting the healthcare travel industry, while cost advantage and marketing effectiveness were less considered. In addition, performance analyse indicated that Thailand has a good performance and stands in the top ranking, followed by Malaysia, India, Singapore, South Korea and Taiwan, respectively. The revenue of Taiwan has increased slowly in the last six years, with a market worth approximately NT$20.5 billion, and the number of medical travelers is expected to increase to 777,523 by 2025. The findings of this study are expected to provide useful information for the medical tourism industry and related key players in strategic planning.Entities:
Keywords: Asia-Pacific region; Grey system theory; Taiwan; economic impact; medical tourism industry; performance evaluation; sustainable development
Mesh:
Year: 2020 PMID: 32033177 PMCID: PMC7037306 DOI: 10.3390/ijerph17030961
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Trends from the medical tourism industry in the Asia-Pacific region. 1 Data collected from the following sources: [19,21,22].
Figure 2Major medical traveler sources in Taiwan.
Figure 3Status of medical tourist and international tourist in Taiwan over the past ten years.
Figure 4Major healthcare services of international patients in Taiwan.
Figure 5Conceptual framework.
Collected measurements and data for analyzing the impact factors of medical tourism industry in the Asia-Pacific region and evaluating performance of each destination.
| Evaluated factors | Measurements | Variable Rename | Destinations | |||||
|---|---|---|---|---|---|---|---|---|
| Thailand | Singapore | Malaysia | South Korea | India | Taiwan | |||
| Tourism resources | Number of international tourist arrivals (1000 million persons) [ | X1 | 35,592 | 13,903 | 25,948 | 13,336 | 15,543 | 10,740 |
| Number of low-cost airlines companies [ | X2 | 6 | 2 | 2 | 6 | 5 | 1 | |
| Travel and Tourism Competitiveness Index [ | X3 | 4.5 | 4.8 | 4.5 | 4.8 | 4.4 | 4.3 | |
| Healthcare resource and medical quality | Number of physicians (per 1000 people) (2017) [ | X4 | 0.8 | 2.3 | 1.5 | 3.7 | 0.8 | 2.2 |
| Current Health Expenditure per capita $US [ | X5 | 221.92 (2016) | 2462.39 (2016) | 361.52 (2016) | 2043.86 (2016) | 62.72 | 2732 | |
| Number of hospital beds per 1000 people [ | X6 | 2.1 | 2.4 | 1.9 | 11.5 | 0.8 | 5.7 | |
| Number of hospitals with joint commission of international accreditation [ | X7 | 68 | 20 | 13 | 24 | 39 | 13 | |
| Marketing effectiveness | Number of medical tourism agencies and facilitations [ | X8 | 8 | 2 | 5 | 2 | 112 | 1 |
| Cost Advantage | Average price of medical procedures | X9 | 11,808 | 12,690 | 8025 | 14,883 | 5783 | 10,167 |
| Medical tourism industry | Medical tourism revenue (US $ million) [ | X10 | 600 | 150 | 350 | 655 | 450 | 300 |
Figure 6Analyzing framework of the Grey model (GM, 0,N) model.
The results of factor analysis by the GM (0,N) model.
| Evaluated Factors | Measurements | Element Weighting | Ranking |
|---|---|---|---|
| Tourism resources | Number of international tourist arrivals | 0.1823 | 8 |
| Number of low-cost airlines companies | 0.1823 | 4 | |
| Travel and Tourism Competitiveness index | 1515.4284 | 1 | |
| Healthcare resources and medical quality | Number of physicians | 1444.9664 | 2 |
| Current Health Expenditure per capita $US | 0.1833 | 7 | |
| Number of hospital beds | 191.8731 | 3 | |
| Number of hospitals with joint commission of international accreditation | 0.7906 | 6 | |
| Marketing effectiveness | Number of medical tourism agencies and facilitations | 1.0052 | 5 |
| Cost Advantage | Average price of medical procedures | 0.0585 | 9 |
Collected variables and situation of Grey relational generation.
| Situation of Grey Relational Generation | Upper Bound Effectiveness Measurement | Lower Bound Effectiveness Measurement | Upper Bound Effectiveness Measurement | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thailand | 35,592 | 6 | 4.5 | 0.8 | 221.92 | 2.1 | 68 | 8 | 11,808 | 600 |
| Singapore | 13,903 | 2 | 4.8 | 2.3 | 2462.39 | 2.4 | 20 | 2 | 12,690 | 150 |
| Malaysia | 25,948 | 2 | 4.5 | 1.5 | 361.52 | 1.9 | 13 | 5 | 8025 | 350 |
| South Korea | 13,336 | 6 | 4.8 | 3.7 | 2043.86 | 11.5 | 24 | 2 | 14,883 | 655 |
| India | 15,543 | 5 | 4.4 | 0.8 | 62.72 | 0.8 | 39 | 112 | 5783 | 450 |
| Taiwan | 10,740 | 1 | 4.3 | 2.2 | 2732 | 5.7 | 13 | 1 | 10,167 | 300 |
Overall performance of six destinations of medical tourism in the Asia-Pacific region.
| Medical Tourism Destinations | Grey Relational Grey Grade (Eigenvalues) | Ranking |
|---|---|---|
| Thailand | 0.966152 | 1 |
| Singapore | 0.893754 | 4 |
| Malaysia | 0.944011 | 2 |
| Taiwan | 0.885301 | 6 |
| India | 0.915399 | 3 |
| South Korea | 0.893026 | 5 |
Note: Results of Grey relational analysis (GRA).
Performance of proposed model.
| Year | Annual Revenue (Billion NT$) | Relative Percentage Error (%) | Number of Medical Tourist (Person) | Relative Percentage Error (%) | ||
|---|---|---|---|---|---|---|
| GM (1,1) Model | Discrete Grey Model (DGM) (1,1) | GM (1,1) Model | DGM (1,1) Model | |||
| 2012 | 9.623 | 173,311 | ||||
| 2013 | 13.648 | 0.35 | 0.52 | 231,164 | 1.02 | 0.51 |
| 2014 | 14.135 | 0.20 | 0.31 | 259,674 | 2.43 | 2.05 |
| 2015 | 15.896 | 7.86 | 7.81 | 305,045 | 8.03 | 7.78 |
| 2016 | 13.99 | 8.27 | 8.26 | 286,599 | 8.39 | 8.55 |
| 2017 | 14.727 | 6.37 | 6.30 | 305,618 | 12.55 | 12.58 |
| 2018 | 17.135 | 5.46 | 5.58 | 414,369 | 8.08 | 8.17 |
| Mean absolute percentage error (MAPE, %) | 4.75 | 4.80 | 6.75 | 6.61 | ||
| Accuracy rate (%) | 95.25% | 95.2% | 93.25% | 93.39% | ||
| Predictive capability | Excellent | Excellent | Good | Good | ||
Figure 7The market size of Taiwan’s medical tourism industry over the next six years.
Estimated values of Taiwan’s medical tourism industry in the next six years.
| Year | Results of the GM (1,1) Model | Results of the DGM (1,1) Model | ||
|---|---|---|---|---|
| Annual Revenue | Number of Medical Tourists | Annual Revenue | Number of Medical Tourist | |
| 2019 | 16.75 | 421,779 | 16.72 | 420,827 |
| 2020 | 17.33 | 467,042 | 17.28 | 465,412 |
| 2021 | 17.92 | 517,163 | 17.86 | 514,721 |
| 2022 | 18.53 | 572,663 | 18.46 | 569,255 |
| 2023 | 19.16 | 634,118 | 19.08 | 629,566 |
| 2024 | 19.82 | 702,169 | 19.72 | 696,267 |
| 2025 | 20.50 | 777,523 | 20.38 | 770,034 |